Dr Liu on the Ongoing Investigation of Zidesamtinib in ROS1+ Tumors
Stephen V. Liu, MD, discusses the potential benefits and ongoing investigation of zidesamtinib for patients with ROS1-positive tumors.
Source: onclive.com
Stephenv Liu News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stephenv Liu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stephenv Liu Today - Breaking & Trending Today
Taletrectinib Continues to Demonstrate High Clinical Activity in Advanced ROS1+ NSCLC
Clinicians discuss data on the ROS1 TKI taletrectinib in patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer.
Source: onclive.com
Dr Liu on the Benefits of Biomarker Testing in NSCLC
Stephen V. Liu, MD, discusses the benefits of conducting biomarker testing for patients with advanced non–small cell lung cancer and highlights the importance of waiting for the results before selecting a targeted treatment.
Source: onclive.com
New Data From 2023 ESMO Congress Further Define the Evolving Role of ADCs in NSCLC
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: onclive.com
Interim Management Strategies Could Aid Patients With Advanced NSCLC Awaiting Biomarker Test Results
Stephen V. Liu, MD, discusses strategies for treatment and disease management for patients with advanced non–small cell lung cancer who are awaiting biomarker test results.
Source: onclive.com